Bacteriophages are interesting viruses that target bacteria and have been used for therapeutic purposes. Recently, the emergence of antibiotic resistance has spurred a renewed interest in using these viruses or their products as therapeutic tools against recalcitrant human pathogens. AAC has also published a recent manuscript from ARLG to guide the use of phages in clinical practice. We will discuss with experts in the field the state-of-the-art in phage therapy.
Objectives:
• Understand the use of bacteriophages and their products for therapeutic purposes
• Discuss the clinical applications of phages
• Debate the barriers for developing of phages as therapeutic tools to treat multidrug-resistant infections
Guests:
• Vincent A. Fischetti, Ph.D, Professor and Director, Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University, New York, NY.
• Saima Aslam, MBBS, Professor of Medicine, University of California San Diego, San Diego, CA.
• Anthony Maresso, PhD. Professor and Founder of TAILOR Labs, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX.
This episode of Editors in Conversation is brought to you by the Antimicrobial Agents and Chemotherapy Journal and hosted by AAC Editor in Chief, Cesar Arias. AAC is available at [ Ссылка ]. Follow Cesar on twitter at [ Ссылка ] for AAC updates.
Subscribe to the podcast at [ Ссылка ]
👍 Subscribe to ASM's YouTube channel at [ Ссылка ]
🔬 Learn more about the American Society for Microbiology at [ Ссылка ]
✅ Become a member today at [ Ссылка ]
📱 Join us on social:
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
Instagram: [ Ссылка ]
